In vitro Antiplasmodial and Cytotoxic activity of Three Medicinal Plants used Traditionally for Treatment of Malaria


Pharmacognosy Communications,2020,10,1,2-6.
Published:December 2019
Type:Original Article

In vitro Antiplasmodial and Cytotoxic activity of Three Medicinal Plants used Traditionally for Treatment of Malaria

Ruth Anyango Omole1,2,*, Mainen Julius Moshi1, Muhammad Ilias3, Walker Larry3, Hamisi M. Malebo4, Leonida Kerubo Omosa5, Jacob O. Midiwo5

1Institute of Traditional Medicine, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, TANZANIA.

2Department of Chemical Science and Technology, Technical University of Kenya, P.O. Box 52428- 00200, Nairobi, KENYA.

3Research Institute of Pharmaceutical Sciences, University of Mississippi, P.O Box 1848-38677 USA.

4Department of Traditional Medicine Research, National Institute for Medical Research, P.O. Box 9653, Dar es Salaam, TANZANIA.

5Department of Chemistry, University of Nairobi, P.O. Box 30197, Chiromo Road, Nairobi, KENYA.


Introduction: Reports of emergence of Artemisinin Combination Therapies (ACTs) resistant malaria parasites in Greater Mekong region and Equatorial Guinea, is a strong reason necessitating increased efforts to discover new antimalarial compounds with novel mechanisms of action. Plants have potential to yield new antiplasmodial compounds. This study investigated the safety and efficacy of three plants; Bersama abyssinica Fresen, Rubus keniensis Standl and Hypoestes verticillaris (L.f.) Sol. ex Roem. and Schult that are used by the Ogiek community of Kenya for treatment of malaria. Methodology: The crude extracts were tested for in vitro antimalarial activity using Plasmodium falciparum strains W2 (chloroquine resistant) and D6 (chloroquine sensitive). Safety evaluation was done using monkey kidney Vero cells and the brine shrimp lethality test. Results: Dichloromethane: methanol (1:1) and 5% aqueous methanol extracts of the three plants exhibited in vitro antiplasmodial activity against the W2 and D6 Plasmodium falciparum strains with IC50= 12.11–19.18 μg/mL, 5.46-7.04 μg/mL and 9.82 – 34.52 μg/mL, respectively. H. verticillaris extracts were the most active against the two Plasmodium falciparum strains. The dichloromethane: methanol extracts of the three plants exhibited lower toxicity on monkey kidney Vero cells relative to antiplasmodial activity as compared to the 5% aqueous methanol extracts. The mean Vero cells: parasite selectivity index of the dichloromethane: methanol extracts was (4.8), B. abyssinica (3.75) and R. keniensis (1.9), while for the 5% aqueous methanol extracts they were H. verticillaris (1.0), B. abyssinica (1.95) and R. keniensis (1.75). A similar toxicity profile was exhibited by brine shrimp lethality results. Conclusion: The results support the use of the three plants for the treatment of malaria. Therefore, they have potential to yield safe and effective compounds targeting P. falciparum malaria.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.